Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.630
+0.320 (13.85%)
At close: Oct 24, 2025, 4:00 PM EDT
2.610
-0.020 (-0.76%)
After-hours: Oct 24, 2025, 7:59 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $425.92 million as of October 24, 2025. Its market cap has decreased by -81.40% in one year.
Market Cap
425.92M
Enterprise Value
228.29M
1-Year Change
-81.40%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $425.92M, a decrease of -83.51%. That is a compound annual growth rate of -57.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 425.92M | -75.13% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.35B |
| Johnson & Johnson | 464.66B |
| AbbVie | 403.98B |
| UnitedHealth Group | 327.39B |
| AstraZeneca | 259.95B |
| Novartis AG | 255.24B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 222.69B |